Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
08/2011
08/04/2011US20110190214 Advantageous Salts of Mu-Opiate Receptor Peptides
08/04/2011US20110190212 Cyclic tetrapeptides
08/04/2011US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/04/2011US20110190138 Methods and compositions for treating conditions
08/04/2011US20110189651 Method and Device for Detecting Feline Immunodeficiency Virus
08/03/2011EP2351833A1 Peptide-containing culture medium for culturing animal cell
08/03/2011EP2350116A1 Treatment of biofilms
08/03/2011EP2350115A1 Antimicrobial compounds
08/03/2011EP2350114A1 Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus
08/03/2011CN102143970A Peptide analogs of alpha-melanocyte stimulating hormone
08/02/2011US7989590 Peptides that increase collagen or hyaluronic acid production
08/02/2011US7989587 SSX-2 peptides presented by HLA class II molecules
08/02/2011US7988974 comprise a macromolecular carrier group fused to a gp41-derived DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LA1 gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells
08/02/2011US7988957 Histone deacetylase inhibitor; adeno-associated virus vector; gene therapy; packages
08/02/2011CA2496538C Boronic ester and acid compounds, synthesis and uses
08/02/2011CA2419285C New uses for amino acid anticonvulsants
08/02/2011CA2321169C Modified enzymes and their use for peptide synthesis
08/02/2011CA2162957C Cinnamic acid derivative
08/02/2011CA2107569C Parathyroid hormone receptor and dna encoding same
07/2011
07/28/2011WO2011091357A1 Aromatic-cationic peptides and uses of same
07/28/2011WO2011089396A2 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use.
07/28/2011WO2011050342A3 Rational design of a biocompatible synthetic laminin-111 polymer and uses thereof
07/28/2011US20110184147 Enzyme substrate for labeling of protein
07/28/2011US20110183925 Anti-inflammatory peptide
07/28/2011US20110183919 Novel dipeptidyl peptidase iv (dp-iv) compounds
07/28/2011US20110183913 Novel lipid dipeptide and gel
07/28/2011US20110183895 Polyheterocyclic compounds highly potent as hcv inhibitors
07/28/2011US20110183891 Methods and Compositions for Inhibiting Fungal Infection and Disease
07/28/2011US20110182864 Compositions containing inclusion complexes
07/28/2011CA2787331A1 Aromatic-cationic peptides and uses of same
07/28/2011CA2786690A1 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
07/27/2011EP2348317A2 Analyzing nerve cell damage
07/27/2011EP1912995B1 Macrocylic inhibitors of hepatitis c virus
07/27/2011EP1432733B1 Method for identifying gene regulatory peptides
07/27/2011CN102137849A Cyclic polyamines for binding phosphatidylserine
07/27/2011CN101591348B Tetrahydrochysene carboline acyl aminoacid benzyl ester, preparation method and application thereof
07/27/2011CN101401941B Preparation and uses of tumor-targeted carrier material RGD-fatty alcohol series of compounds
07/26/2011US7985832 Antimicrobial cathelicidin peptides
07/26/2011US7985771 Furanone derivatives
07/26/2011CA2644467C Alpha crystalline form of perindopril arginine salt, its preparation process, and the pharmaceutical compositions that contain it
07/26/2011CA2334315C Compounds with growth hormone releasing properties
07/21/2011WO2011086553A1 Cyclic peptides, compositions comprising them and uses thereof as nucleases of nucleotidic macromolecules
07/21/2011US20110178270 T-cell death-inducing epitopes
07/21/2011US20110178069 Inhibitors of interleukin-1 beta converting enzyme
07/21/2011US20110178027 Multi-LEU Peptides and Analogues Thereof as Selective PACE4 Inhibitors and Effective Antiproliferative Agents
07/21/2011US20110177077 Pax 5 monoclonal antibody
07/21/2011US20110177030 Hepatitis C Inhibitor Compounds
07/20/2011EP2344518A1 Piperazine compounds with herbicidal effect
07/20/2011EP2344516A1 Pseudoproline dipeptides
07/20/2011EP1545613B1 Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
07/20/2011CN1781933B Thymosin alpha 1 active segment cyclicpeptide analogue and its poly glycol derivative
07/20/2011CN102127144A Neotame-calcium chelate and preparation method thereof
07/20/2011CN102127141A Esculentoside A, EsA as well as preparation method and application thereof
07/19/2011US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
07/19/2011US7981998 Bis-sulfhydryl macrocyclization systems
07/19/2011US7981997 Growth factor which acts through ErbB-4 RTK
07/19/2011US7981862 Composition comprising BMP-2 amplifier/co-activator for enhancement of osteogenesis
07/19/2011CA2448169C Peptides and the use thereof in darkening the skin
07/14/2011WO2011083114A2 Serine hydrolase formulation
07/14/2011US20110172155 Beta thymosin fragments
07/14/2011US20110172145 Antimicrobial compounds
07/14/2011US20110171690 Angiotensin converting enzyme inhibitory peptide
07/14/2011US20110171175 Inhibitors of serine proteases
07/14/2011US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
07/14/2011CA2804034A1 Prodrugs of heteraromatic compounds
07/13/2011EP2343310A1 Serine hydrolase formulation
07/13/2011EP2343290A1 Diamine derivatives as factor X inhibitors
07/13/2011EP2343285A2 Peptoid compounds
07/13/2011EP2343081A1 Interferon analogs
07/13/2011EP1654283B1 Improved method of purifying tfpi and tfpi analogs
07/13/2011CN102124346A Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
07/13/2011CN101044157B Compounds for proteasome enzyme inhibition
07/12/2011US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor
07/12/2011US7977119 Chemical arrays and methods of using the same
07/12/2011CA2470078C Selective urokinase inhibitors
07/07/2011WO2011081523A1 Interferon analogs
07/07/2011WO2011081186A1 Flavor-enriching agent
07/07/2011WO2011081185A1 Flavor-enriching agent
07/07/2011WO2011081184A1 Lanthionine derivative
07/07/2011WO2011080725A1 Compounds with both analgesic and anti-hyperalgesic efficacy
07/07/2011US20110166073 Anti-hypertensive agent
07/07/2011US20110166063 Polymer conjugates of therapeutic peptides
07/07/2011US20110165647 Nanoparticle conjugates
07/07/2011US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
07/07/2011CA2786090A1 Interferon analogs
07/07/2011CA2784310A1 Lanthionine derivatives
07/07/2011CA2783415A1 Kokumi-imparting agent
07/07/2011CA2783413A1 Kokumi-imparting agent
07/06/2011EP2341066A1 Peptide having anti-diabetic activity and use thereof
07/06/2011EP2341065A2 Inhibitors of serine proteases, particularly HCV NS3-NS4a protease
07/06/2011EP2340830A2 Hepatitis C Virus Inhibitors
07/06/2011EP2340822A1 Acylated 4-amidino and 4-guanidinobenzylamines for inhibiting plasma kallikreins
07/06/2011EP2340725A1 Methods for the use of branched chain amino acids
07/06/2011EP2340048A1 Polymer conjugates of biphalin peptides
07/06/2011EP1228076B1 A substantially cell membrane impermeable compound and use thereof
07/06/2011CN101429229B Method for producing high-purity glutathione
07/05/2011US7973219 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
07/05/2011US7973008 Metal-binding compounds and uses therefor
07/05/2011US7972848 Isolation and identification of cross-reactive T cells
07/05/2011US7972808 Digesting polypeptide mixture with proline-specific endoprotease and tripeptidase; recovering tripeptide products
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 307